🧠 neuroscience

Nuclear tau aggregates inhibit RNA export and form by secondary seeding from cytosolic tau aggregates.

This study reveals that nuclear tau aggregates, which form via a VCP-dependent secondary seeding event from pre-existing cytoplasmic aggregates, inhibit mRNA export and disrupt nuclear RNA biogenesis, thereby contributing to tauopathy pathology.

Original authors: Decker, C., McCann, K., Lester, E., Pratt, J., Van Alstyne, M., Wang, Y., Parker, R.

Published 2026-02-18

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Decker, C., McCann, K., Lester, E., Pratt, J., Van Alstyne, M., Wang, Y., Parker, R.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The Big Picture: A "Bad Seed" Spreading Inside the Cell

Imagine a human cell as a bustling factory. Inside this factory, there is a main office (the nucleus) where the blueprints for making products are kept, and a large warehouse floor (the cytoplasm) where the actual work happens.

In diseases like Alzheimer's, a protein called Tau goes wrong. Instead of being a helpful structural beam, it clumps together into sticky, insoluble blobs called aggregates. These blobs are toxic and cause the factory to break down.

This paper asks a specific question: How do these sticky Tau blobs get from the warehouse floor into the main office? And once they get there, what do they do?

1. The Timeline: The Warehouse Mess First

The researchers watched cells over time and discovered a strict order of events. It's like a domino effect:

First: The sticky Tau blobs form in the warehouse (cytoplasm).
Second: A ring of sticky Tau forms around the outside of the main office door (perinuclear ring).
Third: Finally, sticky Tau blobs appear inside the main office (nucleus).

Key Finding: You never see the "office mess" without the "warehouse mess" happening first. The warehouse problem is the cause of the office problem.

2. The Mystery of the "Secret Seed"

Scientists wondered: Do the original sticky blobs just crawl through the door into the office?

To test this, they dyed the original "bad seeds" a bright Red color and watched them.

Result: The Red seeds stayed stuck in the warehouse. They never entered the office.
The Twist: Even though the Red seeds didn't enter, new sticky blobs did appear inside the office.

The Analogy: Imagine a factory where the original bad machines (Red seeds) are stuck in the warehouse. But somehow, the warehouse workers start building new bad machines inside the office, even though the original ones never left the warehouse.

The Culprit: The paper identifies a cellular machine called VCP as the "factory foreman" responsible for this. VCP takes the big, stuck-together Tau blobs in the warehouse, chops them up into tiny, dangerous pieces (new seeds), and sends those tiny pieces into the office to start new trouble. If you stop VCP, the office stays clean, even if the warehouse is a mess.

3. The "Office Manager" (SRRM2)

Inside the main office, there are special zones called Nuclear Speckles. Think of these as the "Filing Cabinets" where the factory keeps its most important blueprints and sorting tools.

The researchers found that a specific protein called SRRM2 (let's call him "The Filing Manager") is crucial for the new bad machines to form in the office.

SRRM2 usually lives in the filing cabinets.
When Tau gets sticky in the warehouse, SRRM2 gets dragged along with it.
SRRM2 has a specific "sticky tail" (a polyserine domain). If you cut off this tail, the new bad machines can't form in the office.

The Analogy: It's like the Filing Manager (SRRM2) is the only one who knows how to unlock the door to the office. Once the warehouse gets messy, the Manager gets pulled into the mess, but he still holds the key. He helps the tiny "bad seeds" get inside the office and start building new sticky blobs right next to the filing cabinets.

4. The Consequence: The Factory Grinds to a Halt

Once the sticky Tau blobs take over the "Filing Cabinets" (Nuclear Speckles) in the main office, the factory stops working correctly.

The Problem: The office is supposed to send finished blueprints (mRNA) out to the warehouse to make products.
The Result: Because the sticky Tau is clogging the filing cabinets, the blueprints get trapped inside the office.
The Evidence: The researchers found twice as many blueprints piled up in the nucleus of cells with Tau aggregates. The "shipping department" is blocked.

Summary: The Chain Reaction

Step 1: Tau gets sticky in the Warehouse (Cytoplasm).
Step 2: The Foreman (VCP) chops these big blobs into tiny, dangerous seeds.
Step 3: The Filing Manager (SRRM2) helps these tiny seeds sneak into the Main Office (Nucleus).
Step 4: The seeds build new sticky blobs inside the Filing Cabinets (Nuclear Speckles).
Step 5: The sticky blobs block the exit, trapping all the important blueprints (RNA) inside the office.

Why does this matter?
This explains how Tau causes cell death. It's not just the sticky blobs themselves; it's the fact that they clog the cell's communication center, stopping the factory from making the proteins it needs to survive. This gives scientists a new target: if we can stop the "Foreman" (VCP) or the "Filing Manager" (SRRM2) from helping these seeds enter the office, we might be able to stop the disease from getting worse.

1. Problem Statement

Tauopathies, including Alzheimer's Disease (AD) and Frontotemporal Dementia (FTD), are characterized by the accumulation of insoluble tau aggregates. While cytoplasmic tau aggregates are well-studied, tau also aggregates in the nucleus, specifically within nuclear speckles (splicing compartments). The mechanisms governing the formation of nuclear tau aggregates, their relationship to cytoplasmic aggregates, and their functional consequences on nuclear physiology remain poorly understood. Key questions include:

Do nuclear aggregates form independently or as a consequence of cytoplasmic aggregates?
Do exogenous seeds directly enter the nucleus, or are new seeds generated intracellularly?
How do nuclear aggregates affect nuclear transport and RNA processing?

2. Methodology

The authors utilized a HEK293T tau biosensor cell line stably expressing a fluorescently tagged 4R tau domain (P301S mutation). Key experimental approaches included:

Seeding Models: Cells were seeded with clarified brain homogenate from Tg2541 tau mice or synthetic fluorescently labeled (Cy3/Cy5) tau fibrils to initiate aggregation.
Live-Cell Imaging: Time-lapse confocal microscopy (CSU-W1 SoRa) was used to track the temporal sequence of aggregate formation (cytoplasmic vs. nuclear) and cell division status.
Exogenous Seed Tracking: Cells were transfected with Cy3-labeled seeds, followed by Cy5-labeled seeds at later time points, to determine if exogenous seeds could enter the nucleus or if nuclear aggregates arose from internal processing.
Pharmacological Inhibition: Treatment with VCP inhibitors (CB-5083 and NMS-873) to test the role of the Valosin-containing protein (VCP) in generating secondary seeds.
Genetic Manipulation:
- siRNA/DsiRNA: Knockdown of nuclear speckle components SRRM2 and PNN.
- CRISPaint/Deletion Mutants: Use of cells expressing SRRM2 lacking polyserine domains to test the requirement of specific protein domains.
RNA Analysis:
- Immunofluorescence: Quantification of RAN (nuclear transport factor) gradients and NLS-mCherry localization to assess nuclear envelope integrity and transport.
- FISH (Fluorescence In Situ Hybridization): Use of oligo(dT) probes for bulk poly(A)+ RNA and specific probes for PEG3, ATF3, and NORAD to assess RNA accumulation and export.
Image Analysis: Automated quantification using CellProfiler and Imaris to measure aggregate frequency, colocalization, and fluorescence intensity.

3. Key Contributions & Results

A. Temporal Sequence of Aggregation

Cytoplasmic Precedence: Nuclear tau aggregates only form in cells that already possess cytoplasmic tau aggregates. No cells were observed with nuclear aggregates lacking cytoplasmic ones.
Mitosis Independence: While ~20% of cells formed nuclear aggregates after mitosis (potentially allowing seed entry during nuclear envelope reassembly), 80% formed nuclear aggregates in non-dividing cells.
Intermediate Stage: In non-dividing cells, a distinct "perinuclear ring" (NR) of tau assemblies forms around the nucleus before nuclear aggregates appear, suggesting a specific intermediate step in the seeding process.

B. Mechanism of Nuclear Seeding (Secondary Seeding)

No Exogenous Seeds in Nucleus: Fluorescently labeled exogenous seeds (Cy3/Cy5) were found exclusively in cytoplasmic aggregates. They never colocalized with nuclear tau aggregates, even when added after cytoplasmic aggregates had formed.
VCP Dependence: Inhibition of VCP (Valosin-containing protein), a chaperone known to extract ubiquitinated proteins from fibrils to generate smaller, seeding-competent species, strongly reduced the formation of nuclear aggregates.
- VCP inhibition did not prevent cytoplasmic aggregation but specifically blocked the transition to nuclear aggregation.
- This indicates that nuclear aggregates arise from secondary seeding events where cytoplasmic aggregates are processed by VCP to generate new, smaller seeds that enter the nucleus.

C. Role of Nuclear Speckle Components

SRRM2 Requirement: Nuclear aggregation is strictly dependent on SRRM2 (Serine/Arginine Repetitive Matrix Protein 2), a core nuclear speckle component.
- Knockdown of SRRM2 reduced nuclear aggregation frequency.
- Depletion of PNN (another speckle component) had no significant effect.
Polyserine Domain: The polyserine-rich domain of SRRM2 is essential. Cells expressing SRRM2 lacking this domain failed to form nuclear aggregates, suggesting this domain facilitates the interaction between tau seeds and the nuclear speckle environment.

D. Impact on Nuclear Transport and RNA

Transport Integrity: Contrary to the hypothesis that aggregates disrupt the nuclear envelope, the study found no defects in the Ran GTPase gradient or NLS-mCherry nuclear import. The nuclear envelope remains intact.
RNA Export Inhibition: Nuclear tau aggregates cause a two-fold increase in nuclear poly(A)+ RNA.
- Specific mRNAs (PEG3, ATF3) and the long non-coding RNA NORAD accumulate in the nucleus.
- FISH analysis shows these RNAs cluster in the periphery of tau aggregates within nuclear speckles.
- This indicates that nuclear tau aggregates specifically inhibit mRNA export, likely by sequestering RNA or disrupting the function of nuclear speckles.

4. Significance

Mechanistic Insight: The paper establishes a clear causal chain: Cytoplasmic aggregates $\rightarrow$ VCP-mediated processing $\rightarrow$ Secondary seed generation $\rightarrow$ Nuclear entry $\rightarrow$ Nuclear speckle aggregation. This refutes the idea that nuclear aggregates are simply a result of passive diffusion of exogenous seeds.
Toxicity Mechanism: The study identifies a novel mechanism of toxicity: nuclear RNA export failure. By trapping poly(A)+ RNA and specific transcripts within nuclear speckles, nuclear tau aggregates disrupt RNA biogenesis and gene expression, which may contribute significantly to neurodegeneration.
Therapeutic Implications: The findings highlight VCP and the SRRM2 polyserine domain as potential therapeutic targets. Inhibiting VCP or disrupting the SRRM2-tau interaction could prevent the formation of nuclear aggregates and the subsequent RNA export blockade, potentially mitigating toxicity in tauopathies.
Disease Relevance: Since nuclear tau aggregates are observed in human patient tissue, these findings suggest that RNA export defects are a critical component of human tauopathy pathology, not just a cell culture artifact.